ESC Premium Access

Addressing cardiovascular risk in type 2 diabetes - The LEADER trial

Event: ESC CONGRESS 2016
Topic: Diabetes management
Session type: Satellite Symposium
Sponsored by Novo Nordisk
Date: 28 August 2016
Time: 18:30 - 20:00

Session

5 presentations in this session

Introduction - Cardiovascular risk in diabetes and cardiovascular outcomes trials - Where do we come from?

Speaker: Professor L. Ryden (Stockholm, SE)
Thumbnail

LEADER – Cardiovascular outcomes & the cardiologist’s perspective.

Speaker: Professor S. Nissen (Cleveland, US)
Thumbnail

LEADER from the diabetologist’s perspective.

Speaker: Professor J. Petrie (Glasgow, GB)
Thumbnail

Cardiovascular outcomes trials in diabetes – What have we learned?

Speaker: Doctor M. Husain (Toronto, CA)
Thumbnail

Question and answers - Addressing cardiovascular risk in type 2 diabetes - The LEADER trial.

Speaker: Professor L. Ryden (Stockholm, SE)
Thumbnail

5 speakers from this session

Professor Lars Ryden

Department of medicine, Karolinska Institutet, Stockholm, Stockholm (Sweden)
31 presentations
0 follower

Professor Steven E Nissen

Cleveland Clinic Foundation, Cleveland (United States of America)
11 presentations
0 follower

Professor John R Petrie

, Glasgow (United Kingdom of Great Britain & Northern Ireland)
2 presentations
0 follower

Doctor Mansoor Husain

University of Toronto, Toronto (Canada)
7 presentations
1 follower

Professor Lars Ryden

Department of medicine, Karolinska Institutet, Stockholm, Stockholm (Sweden)
31 presentations
0 follower

This platform is supported by

logo Novo Nordisk